- /
- Supported exchanges
- / F
- / 0YX.F
Sysmex Corporation (0YX F) stock market data APIs
Sysmex Corporation Financial Data Overview
Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software. It offers non-clinical blood testing and cell analysis for hematology, such as XN-V series, a software for laboratory animal corresponding to XN series fully automated hematology analyzers; XN-Series, a fully automated flagship hematology analyzers; and Automated hematology analyzer ProCyte Dx for Research applications, a housed in a compact body that simultaneously measures five types of leukocytes and reticulocyte counts; coagulation, blood gas/ electrolyte/ urinalysis, cells/ microorganisms, including particle counter/analyzer CDA-1000/1000B, an equipment which is capable of counting cells, yeast, algae, bacteria, and others. The company serves national and other public hospitals, general hospitals, universities, research institutes, other medical institutions, etc. The company was formerly known as TOA Medical Electronics Co., Ltd. and changed its name to Sysmex Corporation in October 1998. Sysmex Corporation was founded in 1968 and is headquartered in Kobe, Japan.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Sysmex Corporation data using free add-ons & libraries
Get Sysmex Corporation Fundamental Data
Sysmex Corporation Fundamental data includes:
- Net Revenue: 502 945 M
- EBITDA: 117 262 M
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-02-12
- EPS/Forecast: 21.84
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Sysmex Corporation News
New
Is It Time To Reassess Sysmex (TSE:6869) After A Prolonged Share Price Slump?
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. If you are wondering whethe...
[Latest] Global Malaria Diagnostics Market Size/Share Worth USD 1.45 Billion by 2035 at a 5.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Malaria Diagnostics Market size & share reven...
Point of Care Diagnostics Market Competitive Landscape Report 2025 Featuring Top 5 Players - Sysmex, Abbott Laboratories, Becton Dickinson and Co, Danaher, Quidel Diagnostics
Company Logo By 2033, the Point of Care (POC) Diagnostics market is projected to reach a valuation of approximately US$ 105.22 billion, driven by an 8.60% CAGR from 2025. This robust growth is fueled...
Fujirebio and Sysmex Begin Sales Collaboration for Dementia Testing
MINATO-KU, TOKYO, Japan & KOBE, Japan, February 05, 2026--(BUSINESS WIRE)--Fujirebio Holdings, Inc. (HQ: Minato-ku, Tokyo; President & CEO: Goki Ishikawa; "Fujirebio"), a consolidated subsidiary of H....
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.